Albert Bourla - Pfizer Insider

Pfizer Inc -- Germany Stock  

EUR 30.5  0.31  1.01%

Group President - Vaccines, Oncology and Consumer Healthcare Business

Mr. Albert Bourla is Group President Pfizer Innovative Health of the company. He was Group President, Global Innovative Pharma Business from February 2016 until June 2016 and Group President, Vaccines, Oncology and Consumer Healthcare since January 2014. President and General Manager of Established Products Business Unit from December 2010 until December 2013. Area President Europe, Africa, Asia and Pacific of Pfizer Animal Health from 2009 until November 2010. Area President Europe, Africa and Middle East of Pfizer Animal Health from 2005 until 2009.
Age: 54  President Since 2016      

Albert Bourla Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 5.27 % which means that it generated profit of $5.27 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 13.68 % meaning that it generated $13.68 on every $100 dollars invested by stockholders.
The company has accumulated 43.87 B in total debt with debt to equity ratio (D/E) of 74.7 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Pfizer Inc has Current Ratio of 1.31 which is within standard range for the sector.

Similar Executives

Entity Summary

Pfizer Inc (PFE) is traded on Frankfurt Stock Exchange in Germany. and employs 28 people.

Did you try this?

Run Stock Tickers Now
   

Stock Tickers

Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Hide  View All  Next  Launch Stock Tickers
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Pfizer Inc to your portfolio

Top Management

Pfizer Inc Leadership Team
John Young, President
Frank DAmelio, President
Douglas Lankler, President
Helen Hobbs, Director, Ph.D
Shantanu Narayen, Director
James Smith, Director
Dennis Ausiello, Director, Ph.D
Mikael Dolsten, President, Ph.D
Frances Fergusson, Director, Ph.D
Stephen Sanger, Director
Suzanne Johnson, Director
Alexander Mackenzie, President
Geno Germano, President
Laurie Olson, President
Sally Susman, President
Anthony Maddaluna, President
Freda LewisHall, President
Rady Johnson, President
W Cornwell, Director
Ian Read, Chairman
James Kilts, Director
Don Cornwell, Director
Charles Hill, President
Joseph Echevarria, Director
Albert Bourla, President
Kirsten LundJurgensen, President
Ronald Blaylock, Director
Kathrin Jansen, President, Ph.D

Stock Performance

Pfizer Performance Indicators